Patents Assigned to Eclipse Bioinnovations, Inc.
  • Patent number: 11795500
    Abstract: The present disclosure relates to methods of identifying RNA targets of RNA binding proteins. In aspects, the disclosure relates to a method of identifying RNA molecules bound by RNA binding proteins. Some embodiments of the present disclosure relate to a method that can definitively identify direct RNA-target interactions with targeted proteins without the requirement for immunoprecipitation or gel extraction. In some embodiments, the method may include combining multiple antibodies in the same sample.
    Type: Grant
    Filed: August 18, 2022
    Date of Patent: October 24, 2023
    Assignee: Eclipse Bioinnovations, Inc.
    Inventors: Daniel A. Lorenz, Karen B. Chapman